Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 17413186)

1.

Novel insights in somatostatin receptor physiology.

Tulipano G, Schulz S.

Eur J Endocrinol. 2007 Apr;156 Suppl 1:S3-11. Review. Erratum in: Eur J Endocrinol. 2007 Oct;157(4):543.

2.

Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.

Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Höllt V, Schulz S.

J Biol Chem. 2004 May 14;279(20):21374-82. Epub 2004 Mar 4.

3.

Novel chimeric somatostatin analogs: facts and perspectives.

Ferone D, Saveanu A, Culler MD, Arvigo M, Rebora A, Gatto F, Minuto F, Jaquet P.

Eur J Endocrinol. 2007 Apr;156 Suppl 1:S23-8. Review. Erratum in: Eur J Endocrinol. 2007 Oct;157(4):543.

4.

Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells.

Roosterman D, Roth A, Kreienkamp HJ, Richter D, Meyerhof W.

J Neuroendocrinol. 1997 Oct;9(10):741-51.

PMID:
9355043
5.

Intracellular trafficking of somatostatin receptors.

Jacobs S, Schulz S.

Mol Cell Endocrinol. 2008 May 14;286(1-2):58-62. Epub 2007 Oct 16. Review.

PMID:
18045773
6.

Receptor signaling and endocytosis are differentially regulated by somatostatin analogs.

Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC, Schonbrunn A.

Mol Pharmacol. 2005 Jul;68(1):90-101. Epub 2005 Apr 26.

7.

Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas.

van der Hoek J, Lamberts SW, Hofland LJ.

Eur J Endocrinol. 2007 Apr;156 Suppl 1:S45-51. Review. Erratum in: Eur J Endocrinol. 2007 Oct;157(4):543.

8.

Evolving concepts in the quest for advanced therapeutic analogues of somatostatin.

Culler MD.

Dig Liver Dis. 2004 Feb;36 Suppl 1:S17-25. Review.

PMID:
15077907
9.

Intracellular degradation of somatostatin-14 following somatostatin-receptor3-mediated endocytosis in rat insulinoma cells.

Roosterman D, Brune NE, Kreuzer OJ, Feld M, Pauser S, Zarse K, Steinhoff M, Meyerhof W.

FEBS J. 2008 Oct;275(19):4728-39. doi: 10.1111/j.1742-4658.2008.06606.x. Epub 2008 Aug 13.

PMID:
18702662
10.

Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.

Nikiforovich GV, Marshall GR, Achilefu S.

Chem Biol Drug Des. 2007 Mar;69(3):163-9.

PMID:
17441902
11.

Somatostatin receptor subtypes: targeting functional and therapeutic specificity.

Culler MD, Taylor JE, Moreau JP.

Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 3):2S5-12. Review.

PMID:
12037501
12.

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.

Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC.

J Biol Chem. 2000 Mar 17;275(11):7862-9.

13.

The two subtype 1 somatostatin receptors of rainbow trout, Tsst1A and Tsst1B, possess both distinct and overlapping ligand binding and agonist-induced regulation features.

Gong JY, Kittilson JD, Slagter BJ, Sheridan MA.

Comp Biochem Physiol B Biochem Mol Biol. 2004 Jul;138(3):295-303.

PMID:
15253878
14.

Somatostatin receptors.

Reisine T.

Am J Physiol. 1995 Dec;269(6 Pt 1):G813-20. Review.

PMID:
8572211
15.
16.

Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2.

Hamdan FF, Rochdi MD, Breton B, Fessart D, Michaud DE, Charest PG, Laporte SA, Bouvier M.

J Biol Chem. 2007 Oct 5;282(40):29089-100. Epub 2007 Aug 3.

17.

Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning.

Durán-Prado M, Malagón MM, Gracia-Navarro F, Castaño JP.

Mol Cell Endocrinol. 2008 May 14;286(1-2):63-8. doi: 10.1016/j.mce.2007.12.006. Epub 2007 Dec 23. Review.

PMID:
18242821
18.

Somatostatin receptor subtypes: basic pharmacology and tissue distribution.

Corleto VD, Nasoni S, Panzuto F, Cassetta S, Delle Fave G.

Dig Liver Dis. 2004 Feb;36 Suppl 1:S8-16. Review.

PMID:
15077906
19.

Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking.

Grant M, Collier B, Kumar U.

J Biol Chem. 2004 Aug 27;279(35):36179-83. Epub 2004 Jul 1.

20.

Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.

Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola E, Pivonello R, Albertelli M, Bianchi F, Giusti M, Minuto F.

J Endocrinol Invest. 2005;28(11 Suppl International):111-7. Review.

PMID:
16625859
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk